Spruce Street Capital LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Spruce Street Capital LP
CRD #333213
SEC #801-132577
CIK #0002050194
AUM 555.9 M (2026-03-02)
Employees 4 (75% Investors, 0% Brokers)
Fees
Minimum
Phone646-416-9712
Address777 Third Avenue
New York, NY 10017
Source [IAPD] [EDGAR] [LinkedIn]
Total AUM ($M)
60048036024012002010201520212027
In the News
Sat, 25 Jul 2026 Spruce Street Capital LP Takes Position in Perspective Therapeutics, Inc. $CATX — MarketBeat
Sat, 25 Jul 2026 Spruce Street Capital LP Makes New $5.97 Million Investment in Maze Therapeutics, Inc. $MAZE — MarketBeat
Sat, 25 Jul 2026 Spruce Street Capital LP Buys Shares of 392,574 Alumis Inc. $ALMS — MarketBeat
Sat, 25 Jul 2026 Spruce Street Capital LP Has $12.90 Million Stock Position in Enliven Therapeutics, Inc. $ELVN — MarketBeat
Sat, 25 Jul 2026 Savara Inc. $SVRA Stock Position Boosted by Spruce Street Capital LP — MarketBeat
Fees and Compensation — Form ADV Part 2A (3/2/2026) [Brochure]
Item 5 – Fees and Compensation

The fees applicable to the Clients are set forth in detail in their investment management agreements. A brief
summary of such fees is provided below.

The Feeder Funds shall pay Spruce Street management fees in accordance with the terms set forth in the
relevant Partnership Agreement (and described in the Memorandum). For the avoidance of doubt, the
Management Fee is expected to generally be paid at the Feeder Fund level, but may be paid at the level of the
Master Fund (without duplication) in the sole discretion of Spruce Street. The management fee is prorated for
any period that is less than a full month. Spruce Street has the authority to waive, reduce or calculate differently
the management fee with respect to any investor in its sole discretion, including investors that are partners,
affiliates or employees of Spruce Street or the fund general partner, members of the immediate family of such
persons and trusts or other entities established by them or for their benefit and certain other persons in the
discretion of Spruce Street. The applicable management fee is generally deducted from each Investor account
by the funds’ administrator upon Spruce Street’s proper instructions.

Expenses

Each Feeder Fund will bear its own expenses and its pro rata share of the Master Fund's expenses, including,
the following: (i) the Management Fee; (ii) expenses related to the research, due diligence, financing, monitoring
and disposition of actual and prospective investments of the Master Fund; (iii) operational expenses; (iv) fees
and expenses of third-party professionals; (v) the costs of any litigation or investigation (or other similar event)
involving activities of a Feeder Fund or the Master Fund; (vi) taxes and third-party audit and tax preparation
expenses; (vii) insurance expenses; (viii) costs of preparing and distributing reports and notices; (ix) expenses
incurred in connection with negotiating, amending, modifying, revising, restating and complying with
provisions of any Side Letter Agreement and other similar arrangements with investors (including vendors and
products related thereto), and expenses incurred in connection with any Transfers of Interests or a Limited
Partner's admission or withdrawal, unless otherwise charged to or borne by the applicable transferee or Limited
Partner; (x) fees and expenses related to compliance with the rules of any self-regulatory organization or
applicable law in connection with the activities of a Feeder Fund or the Master Fund, including, any
governmental, regulatory, licensing, filing or registration fees or taxes and fees and expense of any third-party
compliance consultants; (xi) expenses incurred in connection with the offering and sale of the Interests and
other similar expenses related to a Feeder Fund; (xii) expenses incurred in connection with any amendments,
modifications, revisions or restatements to the constituent documents of a Feeder Fund or the Master Fund;
(xiii) expenses incurred in connection with meetings with investors and prospective investors; (xiv)
extraordinary expenses, including, indemnification expenses and fees and expenses incurred in connection with
any tax audit by any tax authority, including, any related administrative settlement and judicial review; (xv) fees
and expenses incurred in connection with the organization, reorganization, dissolution, winding-up or
termination of a Feeder Fund or the Master Fund; and (xvi) other similar expenses of a Feeder Fund and the
Master Fund. Each Feeder Fund will also indirectly bear any similar expenses of any trading subsidiary or special
purpose vehicle of the Master Fund.

For the avoidance of doubt, "similar expenses" refers to any expenses that are similar in type and nature to the
expenses described above, and is intended, given the dynamic ongoing nature of the business of the Feeder
Funds, to cover any expenses determined by the General Partner, in its sole discretion, to be primarily related
to the categories listed above but not specifically enumerated. Accordingly, any description of the expenses that
a Feeder Fund may bear (directly or indirectly) is not exhaustive.

Generally, all expenses borne by a Feeder Fund, other than (i) the Management Fee, (ii) investment and
investment-related expenses relating specifically to a Private Investment (addressed in the next paragraph), and
(iii) any other expenses that the General Partner determines should be allocated to a particular Partner or
Partners. To the extent that expenses to be borne by a Feeder Fund or the Master Fund are paid by the General
Partner, Spruce Street or their affiliates, the relevant Feeder Fund or the Master Fund, as applicable, will
reimburse such party for such expenses.

Investment and investment-related expenses relating specifically to a Private Investment Account, whether or
not the corresponding Private Investment is consummated, will generally be charged, to the extent practical,
against the Capital Accounts indirectly participating in such Private Investment in proportion to their respective
indirect participating percentage interests therein. It is not always practical or reasonable to allocate investment
and investment-related expenses to a particular Private Investment, such as (i) general research expenses not
related to a specific Private Investment that benefit Private Investments and/or other investments generally,
(ii) research expenses that are subscription-based, aggregated together or otherwise paid for as a single bill or
lump sum payment and (iii) other similar expenses that are difficult to divide and allocate to a single Private
Investment. As a result, such expenses may not be charged solely to the Capital Accounts indirectly participating
in such Private Investment in the manner set forth in the first sentence of this paragraph and instead may be
...
Account Minimums and Types of Clients — Form ADV Part 2A (3/2/2026) [Brochure]
Item 7 – Types of Clients

Spruce Street will offer advisory services to the Client Accounts, as described in Item 4 above, and provide
advisory or other services to other Clients.
Sector Form 13F Holdings Value ($M)
Camp Nine Inc 43.0
Kiniksa Pharmaceuticals Ltd 36.6
LB Pharmaceuticals Inc 33.6
Magenta Therapeutics Inc 31.3
Relay Therapeutics Inc 29.7
Alto Neuroscience Inc 29.1
Adventrx Pharmaceuticals Inc 18.5
Vaxcyte Inc 14.3
Imara Inc 12.9
Consonance-HFW Acquisition Corp 12.6
View All
Holdings by Sector ($M)
4503602701809002025202520262027
Type Form D Funds Date Sold AUM
HF Spruce Street Capital Master Fund LP 2025-03-28 458.3 M
HF Spruce Street Capital Offshore Fund LP [2025-03-28] 152.6 M 338.9 M
Filed 2025-10-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Spruce Street Capital Onshore Fund LP [2025-03-28] 47.7 M 103.7 M
Filed 2025-10-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 4 555.9
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 4 555.9
By Discretionary
Discretionary 4 555.9
Non-Discretionary 0 0.0
Total 4 555.9
By Non-United States Persons
Non-United States Persons 452.1
United States Persons 103.8
Total 4 555.9
Form D Directors Role # Filings # Firms 2011 - 2026
Alex Rosen Executive Officer 7 2
Simon Basseyn Executive Officer 3 2
Spruce Street Capital Fund GP LLC Executive Officer 2 1
Spruce Street Capital LP Promoter 2 1
EDGAR Form CIK 2011 - 2026
13F-HR [0002050194]
SC 13G [0002050194]
Form 13D/13G Filer Form 13D/13G Subject Filed
Spruce Street Capital LP Relmada Therapeutics Inc [2026-02-17]
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesHedge Fund
LEI2549001ICA4Q5ZPPGF12
Comparable Firms State AUM
Pier 88 Investment Partners LLC
CA 568.0 M
Rhino Investment Partners Inc
PA 566.2 M
Stieven Capital Advisors LP
MO 563.4 M
Harraden Circle Investments LLC
NY 562.9 M
Canaras Capital Management LLC
NY 561.0 M
Qvidtvm Management LLC
TX 555.8 M
Avalon Global Asset Management LLC
CA 553.8 M
Northern Right Capital Management LP
CT 552.8 M
Exome Asset Management LLC
NY 548.6 M
TSW II Capital Advisors LLC
TN 544.5 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com